Silicon Valley / San Jose Business Journal
Date: Tuesday, May 31, 2011, 2:40pm PDT
Maxygen Inc.bizWatch said Tuesday it plans to repurchase up to $10 million of its common stock through the end of the year.
Since December 2009, Redwood City-based Maxygen (NASDAQ:MAXY) has bought back about 10 million shares for about $54.1 million.
Last month Maxygen received $76 million in cash from Astellas Bio Inc. for the purchase of Maxygen’s equity interests in Perseid Therapeutics LLC, a former majority-owned subsidiary of Maxygen.
Maxygen also remains eligible for a payment of up to $30 million from Bayer HealthCare LLC related to the sale of hematology assets to Bayer in July 2008
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM